Cargando…
Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions
BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment available for severe combined immunodeficiency (SCID); although, there is a high incidence of severe infections and an increased risk of graft-versus host-disease (GvHD) with HSCT. Early intervention...
Autores principales: | Brodszki, Nicholas, Turkiewicz, Dominik, Toporski, Jacek, Truedsson, Lennart, Dykes, Josefina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714422/ https://www.ncbi.nlm.nih.gov/pubmed/26768987 http://dx.doi.org/10.1186/s13023-016-0385-3 |
Ejemplares similares
-
T-cell depleted haploidentical hematopoietic cell transplantation for pediatric malignancy
por: Takahashi, Takuto, et al.
Publicado: (2022) -
Rapid Memory T-cell Reconstitution Recapitulating CD45RA-depleted Haploidentical Transplant Graft Content in Patients with Hematologic Malignancies
por: Triplett, Brandon M, et al.
Publicado: (2015) -
Selective depletion of naïve T cells by targeting CD45RA
por: Naik, Swati, et al.
Publicado: (2023) -
Recent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescents
por: Im, Ho Joon, et al.
Publicado: (2016) -
The Evolution of T Cell Depleted Haploidentical Transplantation
por: Aversa, Franco, et al.
Publicado: (2019)